Literature DB >> 11270615

The significance of cytomegalovirus infection over the clinical course of adult T-cell leukemia/lymphoma.

H Fujiwara1, Y Eizuru, T Matsumoto, T Kukita, R Imaizumi, H Kawada, H Ohtsubo, K Matsushita, N Arima, C Tei.   

Abstract

The significance of cytomegalovirus (CMV) infections developed over the clinical course of adult T-cell leukemia/lymphoma (ATLL) were evaluated in relation to the patient survival rate, ATL activity and immunocompetent cells. ATLL patients with CMV infections on admission exhibited a poor survival rate, while patients with CMV infections at any time after admission survived longer than those not infected with this virus. ATLL patients who exhibited a numbers of CMV infection on admission showed higher ATL activity and had lower numbers of CD8-positive and CD56-positive cells than those who developed CMV infections at any time after admission. Therefore, it appears likely that patients with CMV infections on admission were in an immunosuppressive state due to aggressive ATL activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270615     DOI: 10.1111/j.1348-0421.2001.tb01265.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients.

Authors:  Junji Ikewaki; Eiichi Ohtsuka; Rie Kawano; Masao Ogata; Hiroshi Kikuchi; Masaru Nasu
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Maintenance and preemptive therapy with ganciclovir for cytomegalovirus colitis with extremely high antigenemia in adult T-cell leukemia.

Authors:  Sumimasa Nagai; Masaki Toshima; Kazuya Sato; Masaki Mori; Tadashi Nagai; Kazuo Muroi; Keiya Ozawa
Journal:  Int J Hematol       Date:  2009-01-20       Impact factor: 2.490

3.  Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.

Authors:  Katja C Erlach; Verena Böhm; Christof K Seckert; Matthias J Reddehase; Jürgen Podlech
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus.

Authors:  Katja C Erlach; Jürgen Podlech; Aysel Rojan; Matthias J Reddehase
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15.

Authors:  Katja C Erlach; Matthias J Reddehase; Jürgen Podlech
Journal:  Med Microbiol Immunol       Date:  2015-03-25       Impact factor: 3.402

Review 6.  Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.

Authors:  Katja C Erlach; Verena Böhm; Martin Knabe; Petra Deegen; Matthias J Reddehase; Jürgen Podlech
Journal:  Med Microbiol Immunol       Date:  2008-02-29       Impact factor: 3.402

7.  Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Authors:  Amit Kumar; Laurie Coquard; Sébastien Pasquereau; Laetitia Russo; Séverine Valmary-Degano; Christophe Borg; Pierre Pothier; Georges Herbein
Journal:  Mol Ther Oncolytics       Date:  2016-04-27       Impact factor: 7.200

Review 8.  Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?

Authors:  Georges Herbein; Zeina Nehme
Journal:  Mol Ther Oncolytics       Date:  2020-03-29       Impact factor: 7.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.